Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States

Author: Silverberg K.   Daya S.   Auray J.P.   Duru G.   Ledger W.   Wikland M.   Bouzayen R.   O'Brien M.   Falk B.   Beresniak A.  

Publisher: Elsevier

ISSN: 0015-0282

Source: Fertility and Sterility, Vol.77, Iss.1, 2002-01, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content